期刊文献+

Alosetron与肠易激综合征

暂未订购
导出
摘要 肠易激综合征( Irritable bowel syndrome, IBS)是一种由于肠功能、感觉和中枢神经系统功能紊乱而引发的常见病,主要症状为腹部疼痛、腹胀及肠功能紊乱,这些症状的出现均与 5- HT3( 5-羟色胺)受体有关。 Alosetron是一种高选择性 5- HT3受体拮抗剂,已被证实对肠易激综合征有一定疗效。多次临床试验显示, Alosetron能明显减轻腹部疼痛,改善肠功能及排便的紧迫感、次数及粘度。
出处 《中国医院用药评价与分析》 2001年第2期115-116,共2页 Evaluation and Analysis of Drug-use in Hospitals of China
  • 相关文献

参考文献8

  • 1Michael JG. New drug in themanagement of the irri-table bowel syndrome[J]. Drugs,1998,56(1):11.
  • 2Gomborone JE,Dewsnap PA,Libby GW,et al. Abdom-ainal illness arritable bowelsyndrome[J]. J Psy Chos-om Res,1995,39:227.
  • 3Kilpatrick GJ,Hagan RM,Butler A,et al. GR68755,a potent and selective antagonist of5-HT3[abstract][J]. Br J pharmacol,1991,104:259.
  • 4Julia A,Barman B,Karen L,et al. Alosetron[J]. Drugs,2000,59(3):511.
  • 5Humphrey PPA,Bountra C,Clayton N,et al. Review ar-ticle:the therapeutic potentialof 5-HT3 receptor antag-onists in the treatment of irritable bowel syndrome[J]. AlimentPharmacol Ther,1999,13(Suppl,2):31.
  • 6Delvaux M,Louvel D,Mamet JP. Effect of alosetron on responses to colonic distensionin patients with irritable bowel syndrome[J]. Aliment Pharmacol Ther,1998,12:849.
  • 7Bearcroft CP,Andre EA,Farthing MJG. In vivo effects of the 5-HT3 antagonistalosetron on basal and cholera toxin-in-duced secretion in the human jejunum:aseg-mental perfusion study[J]. Aliment Pharmacol Ther,1997,11:1 109.
  • 8Bardhan KD,Bodemar G,Geldof Ⅱ,et al. A double-bli-nd,randomized,placebo-controlleddose-ranging stu-dy to evaluate the efficacy of alosetron in the treatment of irritablebowel syndrome[J]. Aliment Pharmacol Th-er,2000,14:23.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部